Peptic ulcer disease and non-steroidal anti-inflammatory drugs

Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers....

Full description

Saved in:
Bibliographic Details
Published in:Australian prescriber 2017-06, Vol.40 (3), p.91-93
Main Author: Drini, Musa
Format: Article
Language:English
Subjects:
Anti-inflammatory agents
Anticoagulants
Aspirin
Biosynthesis
Data analysis
Disease prevention
Drug dosages
Nonsteroidal anti-inflammatory drugs
Prescription drugs
Protons
Risk factors
Steroids
Ulcers
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c502t-de8512219c79a0fad97ca65af63edb910a6856facb543b6fd70679e28ceade2d3
cites
container_end_page 93
container_issue 3
container_start_page 91
container_title Australian prescriber
container_volume 40
creator Drini, Musa
description Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers. Patients at high risk may require co-prescription to reduce the risk of peptic ulcers. A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.
doi_str_mv 10.18773/austprescr.2017.037
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5478398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1928506800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-de8512219c79a0fad97ca65af63edb910a6856facb543b6fd70679e28ceade2d3</originalsourceid><addsrcrecordid>eNpdkFtLAzEQhYMotlb_gciCL75szaXZJC-CFG9Q0Ad9XmaT2ZqyN5Ndof_eFauoTwMzH2fOOYScMjpnWilxCUPsu4DRhjmnTM2pUHtkyrQwqTALvk-mVDCeakr1hBzFuKGUUymzQzLhWhktGZ-Sqyfsem-TobIYEucjQsQEGpc0bZPGHkPrHVTjpvepb8oK6hr6NmwTF4Z1PCYHJVQRT3ZzRl5ub56X9-nq8e5heb1KraS8Tx1-fuPMWGWAluCMspBJKDOBrjCMQqZlVoIt5EIUWekUzZRBri2CQ-7EjFx96XZDUaOz2PQBqrwLvoawzVvw-d9L41_zdfuey4UaC9GjwMVOILRvA8Y-r320WFXQYDvEnBmuJc3Gskb0_B-6aYfQjPFyPgJMcaHESJ39dvRj5bta8QEUk39L</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2680172373</pqid></control><display><type>article</type><title>Peptic ulcer disease and non-steroidal anti-inflammatory drugs</title><source>PubMed (Medline)</source><creator>Drini, Musa</creator><creatorcontrib>Drini, Musa</creatorcontrib><description>Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers. Patients at high risk may require co-prescription to reduce the risk of peptic ulcers. A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.</description><identifier>ISSN: 0312-8008</identifier><identifier>EISSN: 1839-3942</identifier><identifier>DOI: 10.18773/austprescr.2017.037</identifier><identifier>PMID: 28798512</identifier><language>eng</language><publisher>Australia: Therapeutic Guidelines Limited</publisher><subject>Anti-inflammatory agents ; Anticoagulants ; Aspirin ; Biosynthesis ; Data analysis ; Disease prevention ; Drug dosages ; Nonsteroidal anti-inflammatory drugs ; Prescription drugs ; Protons ; Risk factors ; Steroids ; Ulcers</subject><ispartof>Australian prescriber, 2017-06, Vol.40 (3), p.91-93</ispartof><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 NPS MedicineWise</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-de8512219c79a0fad97ca65af63edb910a6856facb543b6fd70679e28ceade2d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478398/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478398/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28798512$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Drini, Musa</creatorcontrib><title>Peptic ulcer disease and non-steroidal anti-inflammatory drugs</title><title>Australian prescriber</title><addtitle>Aust Prescr</addtitle><description>Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers. Patients at high risk may require co-prescription to reduce the risk of peptic ulcers. A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.</description><subject>Anti-inflammatory agents</subject><subject>Anticoagulants</subject><subject>Aspirin</subject><subject>Biosynthesis</subject><subject>Data analysis</subject><subject>Disease prevention</subject><subject>Drug dosages</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Prescription drugs</subject><subject>Protons</subject><subject>Risk factors</subject><subject>Steroids</subject><subject>Ulcers</subject><issn>0312-8008</issn><issn>1839-3942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkFtLAzEQhYMotlb_gciCL75szaXZJC-CFG9Q0Ad9XmaT2ZqyN5Ndof_eFauoTwMzH2fOOYScMjpnWilxCUPsu4DRhjmnTM2pUHtkyrQwqTALvk-mVDCeakr1hBzFuKGUUymzQzLhWhktGZ-Sqyfsem-TobIYEucjQsQEGpc0bZPGHkPrHVTjpvepb8oK6hr6NmwTF4Z1PCYHJVQRT3ZzRl5ub56X9-nq8e5heb1KraS8Tx1-fuPMWGWAluCMspBJKDOBrjCMQqZlVoIt5EIUWekUzZRBri2CQ-7EjFx96XZDUaOz2PQBqrwLvoawzVvw-d9L41_zdfuey4UaC9GjwMVOILRvA8Y-r320WFXQYDvEnBmuJc3Gskb0_B-6aYfQjPFyPgJMcaHESJ39dvRj5bta8QEUk39L</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Drini, Musa</creator><general>Therapeutic Guidelines Limited</general><general>NPS MedicineWise</general><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170601</creationdate><title>Peptic ulcer disease and non-steroidal anti-inflammatory drugs</title><author>Drini, Musa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-de8512219c79a0fad97ca65af63edb910a6856facb543b6fd70679e28ceade2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anti-inflammatory agents</topic><topic>Anticoagulants</topic><topic>Aspirin</topic><topic>Biosynthesis</topic><topic>Data analysis</topic><topic>Disease prevention</topic><topic>Drug dosages</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Prescription drugs</topic><topic>Protons</topic><topic>Risk factors</topic><topic>Steroids</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Drini, Musa</creatorcontrib><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Australian prescriber</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Drini, Musa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptic ulcer disease and non-steroidal anti-inflammatory drugs</atitle><jtitle>Australian prescriber</jtitle><addtitle>Aust Prescr</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>40</volume><issue>3</issue><spage>91</spage><epage>93</epage><pages>91-93</pages><issn>0312-8008</issn><eissn>1839-3942</eissn><abstract>Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers. Patients at high risk may require co-prescription to reduce the risk of peptic ulcers. A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.</abstract><cop>Australia</cop><pub>Therapeutic Guidelines Limited</pub><pmid>28798512</pmid><doi>10.18773/austprescr.2017.037</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0312-8008
ispartof Australian prescriber, 2017-06, Vol.40 (3), p.91-93
issn 0312-8008
1839-3942
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5478398
source PubMed (Medline)
subjects Anti-inflammatory agents
Anticoagulants
Aspirin
Biosynthesis
Data analysis
Disease prevention
Drug dosages
Nonsteroidal anti-inflammatory drugs
Prescription drugs
Protons
Risk factors
Steroids
Ulcers
title Peptic ulcer disease and non-steroidal anti-inflammatory drugs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A38%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptic%20ulcer%20disease%20and%20non-steroidal%20anti-inflammatory%20drugs&rft.jtitle=Australian%20prescriber&rft.au=Drini,%20Musa&rft.date=2017-06-01&rft.volume=40&rft.issue=3&rft.spage=91&rft.epage=93&rft.pages=91-93&rft.issn=0312-8008&rft.eissn=1839-3942&rft_id=info:doi/10.18773/austprescr.2017.037&rft_dat=%3Cproquest_pubme%3E1928506800%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-de8512219c79a0fad97ca65af63edb910a6856facb543b6fd70679e28ceade2d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2680172373&rft_id=info:pmid/28798512&rfr_iscdi=true